0001416876 2026-01-01 2026-06-30 0001416876 2026-08-13 0001416876 2026-06-30 0001416876 2025-12-31 0001416876 FCHS:SeriesASuperVotingPreferredStockMember 2026-06-30 0001416876 FCHS:SeriesASuperVotingPreferredStockMember 2025-12-31 0001416876 FCHS:SeriesBConvertiblePreferredStockMember 2026-06-30 0001416876 FCHS:SeriesBConvertiblePreferredStockMember 2025-12-31 0001416876 us-gaap:SeriesCPreferredStockMember 2026-06-30 0001416876 us-gaap:SeriesCPreferredStockMember 2025-12-31 0001416876 us-gaap:SeriesEPreferredStockMember 2026-06-30 0001416876 us-gaap:SeriesEPreferredStockMember 2025-12-31 0001416876 2026-04-01 2026-06-30 0001416876 2025-04-01 2025-06-30 0001416876 2025-01-01 2025-06-30 0001416876 us-gaap:CommonStockMember 2024-12-31 0001416876 us-gaap:PreferredStockMember 2024-12-31 0001416876 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001416876 us-gaap:RetainedEarningsMember 2024-12-31 0001416876 2024-12-31 0001416876 us-gaap:CommonStockMember 2025-03-31 0001416876 us-gaap:PreferredStockMember 2025-03-31 0001416876 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001416876 us-gaap:RetainedEarningsMember 2025-03-31 0001416876 2025-03-31 0001416876 us-gaap:CommonStockMember 2025-12-31 0001416876 us-gaap:PreferredStockMember 2025-12-31 0001416876 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001416876 us-gaap:RetainedEarningsMember 2025-12-31 0001416876 us-gaap:CommonStockMember 2026-03-31 0001416876 us-gaap:PreferredStockMember 2026-03-31 0001416876 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001416876 us-gaap:RetainedEarningsMember 2026-03-31 0001416876 2026-03-31 0001416876 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001416876 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001416876 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001416876 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001416876 2025-01-01 2025-03-31 0001416876 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001416876 us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001416876 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001416876 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001416876 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001416876 us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001416876 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001416876 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001416876 2026-01-01 2026-03-31 0001416876 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001416876 us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001416876 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001416876 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001416876 us-gaap:CommonStockMember 2025-06-30 0001416876 us-gaap:PreferredStockMember 2025-06-30 0001416876 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001416876 us-gaap:RetainedEarningsMember 2025-06-30 0001416876 2025-06-30 0001416876 us-gaap:CommonStockMember 2026-06-30 0001416876 us-gaap:PreferredStockMember 2026-06-30 0001416876 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001416876 us-gaap:RetainedEarningsMember 2026-06-30 0001416876 us-gaap:ConvertibleDebtSecuritiesMember 2026-01-01 2026-06-30 0001416876 us-gaap:ConvertibleDebtSecuritiesMember 2025-01-01 2025-06-30 0001416876 FCHS:WarrantsToPurchaseCommonStockMember 2026-01-01 2026-06-30 0001416876 FCHS:WarrantsToPurchaseCommonStockMember 2025-01-01 2025-06-30 0001416876 FCHS:IncentiveSharesPayableIssuedWithNonConvertibleNotesMember 2026-01-01 2026-06-30 0001416876 FCHS:IncentiveSharesPayableIssuedWithNonConvertibleNotesMember 2025-01-01 2025-06-30 0001416876 us-gaap:RestrictedStockMember 2026-01-01 2026-06-30 0001416876 us-gaap:RestrictedStockMember 2025-01-01 2025-06-30 0001416876 srt:MinimumMember 2026-06-30 0001416876 srt:MaximumMember 2026-06-30 0001416876 FCHS:EighteenNonConvertibleNotesPayableMember 2021-12-31 0001416876 FCHS:NonConvertibleNotesPayableMember 2024-01-01 2024-12-31 0001416876 FCHS:NonConvertibleNotesPayableMember 2023-01-01 2023-12-31 0001416876 FCHS:TwentyPercentageCashPaymentNotesMember FCHS:NonConvertibleNotesPayableMember 2026-06-30 0001416876 FCHS:TwentyPercentageCashPaymentNotesMember FCHS:NonConvertibleNotesPayableMember 2025-12-31 0001416876 FCHS:PaycheckProtectionPlanLoanMember 2020-01-01 2020-12-31 0001416876 FCHS:PaycheckProtectionPlanLoanMember 2021-02-19 2021-02-19 0001416876 FCHS:PaycheckProtectionPlanLoanMember 2025-04-24 2025-04-24 0001416876 FCHS:OtherNonConvertibleNotesMember 2026-06-30 0001416876 FCHS:OtherNonConvertibleNotesMember 2025-12-31 0001416876 srt:MaximumMember FCHS:OtherNonConvertibleNotesMember 2026-06-30 0001416876 FCHS:OtherNonConvertibleNotesMember FCHS:RidgecrestCapitalMember 2026-06-30 0001416876 FCHS:OtherNonConvertibleNotesMember FCHS:BeydoggLLCMember 2026-06-30 0001416876 FCHS:OtherNonConvertibleNotesMember srt:ChiefFinancialOfficerMember 2026-06-30 0001416876 srt:ChiefExecutiveOfficerMember FCHS:OtherNonConvertibleNotesMember 2025-12-31 0001416876 FCHS:MultipleRelatedPartiesMember FCHS:OtherNonConvertibleNotesMember 2025-12-31 0001416876 FCHS:OtherNonConvertibleNotesMember 2026-01-01 2026-06-30 0001416876 FCHS:OtherNonConvertibleNotesMember 2025-01-01 2025-06-30 0001416876 FCHS:TenPercentOIDSeniorSecuredConvertibleNotesMember FCHS:SecurityPurchaseAgreementsMember 2026-01-01 2026-06-30 0001416876 FCHS:TenPercentOIDSeniorSecuredConvertibleNotesMember 2026-01-01 2026-06-30 0001416876 FCHS:TenPercentOIDSeniorSecuredConvertibleNotesMember us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-06-30 0001416876 FCHS:TenPercentOIDSeniorSecuredConvertibleNotesMember us-gaap:SeriesEPreferredStockMember 2026-01-01 2026-06-30 0001416876 FCHS:TenPercentOIDSeniorSecuredConvertibleNotesMember 2025-12-31 0001416876 FCHS:ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember 2026-01-01 2026-06-30 0001416876 FCHS:ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-06-30 0001416876 FCHS:ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember us-gaap:SeriesEPreferredStockMember 2026-01-01 2026-06-30 0001416876 FCHS:ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember 2025-12-31 0001416876 FCHS:ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember 2025-01-01 2025-06-30 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember 2026-01-01 2026-06-30 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember 2026-06-30 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember 2025-12-31 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNotesPayableOneMember 2026-06-30 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNotesPayableOneMember 2025-12-31 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember us-gaap:SeriesEPreferredStockMember 2026-01-01 2026-06-30 0001416876 FCHS:TwentyPercentOIDConvertibleNotesPayableMember 2026-01-01 2026-06-30 0001416876 FCHS:TenPercentOIDSeniorSecuredConvertibleNotesMember us-gaap:ConvertibleNotesPayableMember 2026-06-30 0001416876 FCHS:TenPercentOIDSeniorSecuredConvertibleNotesMember us-gaap:ConvertibleNotesPayableMember 2025-12-31 0001416876 FCHS:ThirtyFivePercentOIDSeniorSecuredConvertibleNotesMember us-gaap:ConvertibleNotesPayableMember 2026-06-30 0001416876 FCHS:ThirtyFivePercentOIDSeniorSecuredConvertibleNotesMember us-gaap:ConvertibleNotesPayableMember 2025-12-31 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNotesMember us-gaap:ConvertibleNotesPayableMember 2026-06-30 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNotesMember us-gaap:ConvertibleNotesPayableMember 2025-12-31 0001416876 us-gaap:ConvertibleNotesPayableMember 2026-06-30 0001416876 us-gaap:ConvertibleNotesPayableMember 2025-12-31 0001416876 FCHS:TenPercentOIDSeniorSecuredConvertibleNotesMember 2026-06-30 0001416876 FCHS:TenPercentOIDSeniorSecuredConvertibleNotesMember 2025-12-31 0001416876 FCHS:ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember 2026-01-01 2026-06-30 0001416876 FCHS:ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember 2025-01-01 2025-12-31 0001416876 FCHS:ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember 2026-06-30 0001416876 FCHS:ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember 2025-12-31 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember 2026-06-30 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember 2025-12-31 0001416876 2021-01-01 0001416876 FCHS:OfficeMember 2021-01-01 0001416876 FCHS:ClinicFacilityMember 2021-01-01 0001416876 FCHS:ClinicFacilityMember 2024-08-01 0001416876 FCHS:ClinicFacilityMember 2024-09-01 0001416876 2016-03-31 2016-03-31 0001416876 2021-10-12 2021-10-12 0001416876 2023-01-01 2023-12-31 0001416876 2023-12-31 0001416876 FCHS:LeaseAgreementMember 2018-05-31 2018-05-31 0001416876 FCHS:LeaseAgreementMember 2018-05-31 0001416876 FCHS:LeaseAgreementMember 2023-06-30 0001416876 FCHS:FirstChoiceMedicalGroupMember 2026-06-30 0001416876 FCHS:TheGoodClinicMember 2026-06-30 0001416876 FCHS:FirstChoiceHealthcareSolutionsConsolidatedMember 2026-06-30 0001416876 2021-10-19 2021-10-19 0001416876 2021-11-15 2021-11-15 0001416876 2021-12-15 2021-12-15 0001416876 2022-01-07 2022-01-07 0001416876 2022-01-15 2022-01-15 0001416876 2022-02-08 2022-02-08 0001416876 2022-02-15 2022-02-15 0001416876 FCHS:SeriesBPreferredConvertibleStockMember 2026-06-30 0001416876 FCHS:SeriesCConvertiblePreferredStockMember 2026-06-30 0001416876 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2026-06-30 0001416876 FCHS:SeriesASuperVotingPreferredStockMember us-gaap:PreferredStockMember 2026-06-30 0001416876 FCHS:SeriesCConvertiblePreferredStockMember us-gaap:PreferredStockMember 2026-06-30 0001416876 FCHS:SeriesASuperVotingPreferredStockMember 2026-01-01 2026-06-30 0001416876 FCHS:SeriesBPreferredConvertibleStockMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001416876 FCHS:SeriesBTenPercentageConvertiblePreferredStockMember 2026-01-01 2026-06-30 0001416876 us-gaap:SeriesBPreferredStockMember 2022-04-01 2022-06-30 0001416876 us-gaap:SeriesBPreferredStockMember 2022-06-30 0001416876 FCHS:FifteenInvestorsMember us-gaap:SeriesBPreferredStockMember 2022-06-30 0001416876 FCHS:FifteenInvestorsMember us-gaap:SeriesBPreferredStockMember 2022-04-01 2022-06-30 0001416876 FCHS:SeriesBTenPercentageConvertiblePreferredStockMember 2023-04-01 2023-06-30 0001416876 FCHS:SeriesBTenPercentageConvertiblePreferredStockMember 2023-06-30 0001416876 FCHS:OneInvestorMember FCHS:SeriesBTenPercentageConvertiblePreferredStockMember 2023-06-30 0001416876 FCHS:OneInvestorMember FCHS:SeriesBTenPercentageConvertiblePreferredStockMember 2023-04-01 2023-06-30 0001416876 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001416876 FCHS:SeriesCPreferredConvertibleStockMember 2026-06-30 0001416876 FCHS:SeriesCPreferredConvertibleStockMember 2026-01-01 2026-06-30 0001416876 FCHS:SeriesEPreferredConvertibleStockMember 2026-01-01 2026-06-30 0001416876 srt:MaximumMember FCHS:SeriesEPreferredConvertibleStockMember 2026-01-01 2026-06-30 0001416876 srt:MinimumMember FCHS:SeriesEPreferredConvertibleStockMember 2026-01-01 2026-06-30 0001416876 FCHS:ThirtyFivePercentageOIDSuperPriorityConvertibleNotesTwoThousandTwentyTwoMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001416876 FCHS:ThirtyFivePercentageOIDSuperPriorityConvertibleNotesTwoThousandTwentyThreeMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001416876 FCHS:TwentyPercentageOIDConvertibleNotesTwoThousandTwentyThreeMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001416876 FCHS:TenPercentOIDSeniorSecuredConvertibleNotesMember us-gaap:WarrantMember 2026-06-30 0001416876 srt:MinimumMember FCHS:TenPercentOIDSeniorSecuredConvertibleNotesMember us-gaap:WarrantMember 2026-06-30 0001416876 FCHS:ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember us-gaap:WarrantMember 2026-06-30 0001416876 srt:MinimumMember FCHS:ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember us-gaap:WarrantMember 2026-06-30 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember us-gaap:WarrantMember 2026-06-30 0001416876 FCHS:SeriesBPreferredConvertibleStockMember us-gaap:WarrantMember 2026-06-30 0001416876 srt:MinimumMember FCHS:SeriesBPreferredConvertibleStockMember us-gaap:WarrantMember 2026-06-30 0001416876 FCHS:NonConvertibleNotesMember us-gaap:WarrantMember 2026-06-30 0001416876 FCHS:OtherWarrantsMember 2026-06-30 0001416876 FCHS:OneHolderMember FCHS:OtherWarrantsMember 2026-06-30 0001416876 FCHS:SecondHolderMember FCHS:OtherWarrantsMember 2026-06-30 0001416876 FCHS:ThirdHolderMember FCHS:OtherWarrantsMember 2026-06-30 0001416876 FCHS:TwoSeparateHolderMember FCHS:OtherWarrantsMember 2026-06-30 0001416876 FCHS:OtherWarrantsMember 2026-01-01 2026-06-30 0001416876 us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-12-31 0001416876 FCHS:SeriesETenPercentageConvertiblePreferredStockMember FCHS:SeriesEPreferredConvertibleStockMember 2026-06-30 0001416876 FCHS:SeriesEThirtyFivePercentageConvertiblePreferredStockMember FCHS:SeriesEPreferredConvertibleStockMember 2026-06-30 0001416876 FCHS:SeriesETwentyPercentageConvertiblePreferredStockMember FCHS:SeriesEPreferredConvertibleStockMember 2026-06-30 0001416876 FCHS:SeriesEPreferredConvertibleStockMember 2026-06-30 0001416876 FCHS:ThirtyFivePercentOIDSeniorSecuredConvertibleNotesMember 2026-06-30 0001416876 FCHS:ThirtyFivePercentOIDSeniorSecuredConvertibleNotesMember 2025-12-31 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNoteMember 2026-06-30 0001416876 FCHS:TwentyPercentOIDSeniorSecuredConvertibleNoteMember 2025-12-31 0001416876 FCHS:SeriesBPreferredConvertibleStockMember 2026-06-30 0001416876 FCHS:SeriesBPreferredConvertibleStockMember 2025-12-31 0001416876 FCHS:SeriesCWarrantsMember 2026-06-30 0001416876 FCHS:SeriesCWarrantsMember 2025-12-31 0001416876 FCHS:SeriesEWarrantStockMember 2026-06-30 0001416876 FCHS:SeriesEWarrantStockMember 2025-12-31 0001416876 FCHS:NonConvertibleNotesMember 2026-06-30 0001416876 FCHS:NonConvertibleNotesMember 2025-12-31 0001416876 FCHS:OtherWarrantsMember 2026-06-30 0001416876 FCHS:OtherWarrantsMember 2025-12-31 0001416876 us-gaap:WarrantMember 2025-12-31 0001416876 us-gaap:WarrantMember 2026-01-01 2026-06-30 0001416876 us-gaap:WarrantMember 2026-06-30 iso4217:USD shares iso4217:USD shares pure false --12-31 Q2 0001416876

10-Q true 2026-06-30 2026 false 000-53012 FIRST CHOICE HEALTHCARE SOLUTIONS, INC. DE 90-0687379 95 Bulldog Blvd Suite 202 Melbourne FL 32901 (321) 725-0090 Yes Yes Non-accelerated Filer true false false 32958288 0.001

6842

5896

403

717

7245

6613

141148

146961

3350511

428100

543345

576493

4047430

4426068

13115035

382121

5658513

27177660

10084581

40674816

2900690

10084581

43575506

0.01

40000

147

0.001

100000000

32958288

32958

0.01

56000

22243

22242837

0.01

50000

16271

16271315

35135111

35182032

74453

-83190310

-74743067

-9508087

-39528075

576493

4047430

1423 5456

1423

5456

96802

143578

199053

255241

439176

432259

1068258

909087

535978

575837

1267310

1164328

-535978

-574414

-1267310

-1158872

8219

-20788

-48328

101746 101746 471300 471300

299375

6681244

515534

7385781

1301429

-6475396

-65022

-7179933

-878457

-7011374

-639436

-8447243

-2037329

-7011374

-639436

-8447243

-2037329

-7011374

-639436

-8447243

-2037329

-0.21

-0.02

-0.26

-0.06

32958288

32958

147

35276650

-67781149

-32471540

23460

-1397892

32958288

32958

147

35253190

-69179041

-33892892

23461

-639436

32958288

32958

147

35229729

-69818477

-34555789

32958288

32958

147

35182032

-74743067

-39528075

23460

-1435869

32958288

32958

147

35158571

-76178936

-40987405

32958288

32958

147

35158571

-76178936

-40987405

38514

38514152

23460

-7011374

32958288

32958

38661

38514153

35135111

-83190310

-9508087

32958288

32958

38661

38514153

35135111

-83190310

-9508087

-8447243

-2037329

5813

9733

-48327

471300

7385781

1301429

101746

299375

145665

-11403

-482383 -195484 -732506 -694968

-184054

-247285

10000

90000

200000

385000

455454

185000

365454

946

128169

5896

19915

6842

148084

NOTE 1— ORGANIZATION, BUSINESS AND PRINCIPLES OF CONSOLIDATION First Choice Healthcare Solutions, Inc. (“FCHS,” “the Company,” “we,” “our” or “us”) is actively engaged in implementing a defined growth strategy aimed at building a network of localized, integrated healthcare services platforms, comprised of nurse practitioner driven primary care clinics providing services including family primary care, anti-aging, dermatology, weight loss, hormone replacement therapy, functional and genetic testing, nutritional counseling, as well as behavioral health. The audited condensed consolidated financial statements of First Choice Healthcare Solutions, Inc., a Delaware corporation, since February 13, 2012, include the accounts of the Company and its direct and indirect wholly owned subsidiaries: FCID Medical, Inc. (“FCID Medical”) is the subsidiary under which we own and operate First Choice Medical Group of Brevard, LLC, (“FCMG”), our original medical services practice, and The Good Clinic Properties, LLC. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all the information and disclosures required by U.S. GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the unaudited condensed consolidated financial statements of the Company as of June 30, 2026, and for the six months ended June 30, 2026 and 2025. The results of operations for the six months ended June 30, 2026, are not necessarily indicative of the operating results for the full year ending December 31, 2026, or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures of the Company as of December 31, 2025, and for the year then ended, which were filed with the Securities and Exchange Commission (“SEC”) on Form 10-K on March 11, 2026.

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES Use of estimates The preparation of the financial statements in conformity with U. S. GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates include the recoverability and useful lives of long-lived assets, provision against bad debt, the fair value of the Company’s stock, and stock-based compensation. Actual results may differ from these estimates. For purposes of clarity and ease of presentation, all dollar amounts in these financial statements have been rounded to the nearest whole number. However, the underlying data used in the calculations is not rounded, and the totals presented may differ by a small amount due to rounding. These differences are considered immaterial and do not affect the overall financial position or results of operations. Revenue Recognition The Company recognizes revenue when: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed or determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management’s judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. Patient Service Revenue Our revenues relate to net patient fees received from various payers and patients themselves under contracts in which our performance obligations are to provide services to the patients. Revenues are recorded during the period our obligations to provide services are satisfied. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify payments at amounts less than our standard charges and provide for payments based upon predetermined rates for services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals. Concentrations of credit risk The Company’s financial instruments are exposed to a concentration of customer risk and accounts receivable risk. Occasionally, the Company’s cash and cash equivalents in interest-bearing accounts may exceed FDIC insurance limits. The financial stability of these institutions is periodically reviewed by senior management. Accounts receivable Accounts receivables are carried at their estimated collectible amounts net of doubtful accounts. The Company analyzes its history and identifies trends for each major payer sources of revenue to estimate the appropriate allowance for doubtful accounts and provision for bad debts. Management regularly reviews data about these major payer sources of revenue in evaluating the sufficiency of the contractual allowances. Patient receivables are accounts receivable from services provided to patients who have third-party coverage. The Company analyzes contractually due amounts and provides a provision for bad debts, if necessary. The Company records a provision for bad debts in the period of service on the basis of past experience or when indications are the patients are unable or unwilling to pay the portion of their bill for which they are responsible. The difference between the standard rates (or the discounted rates if negotiated) and the amounts actually collected after all reasonable collection efforts have been exhausted, is charged off against the allowance for doubtful accounts. Net loss per share Basic net loss per common share is based upon the weighted-average number of common shares outstanding. Diluted net loss per common share is the same as basic net loss per common share as the inclusion of potentially dilutive common shares would be anti-dilutive. SCHEDULE OF BASIC NET LOSS PER COMMON SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20260101__20260630_zTdDcNCd53ai" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20250101__20250630_zafdiRRjabOj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six months ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zA25MAfd2yIe" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Net loss attributable to First Choice Healthcare Solutions, Inc.</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(8,447,243</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(2,037,329</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Weighted average common shares, basic and dilutive</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">32,958,288</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">32,958,288</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and dilutive loss per common share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.26</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td></tr> </table> Basic net loss per share is computed on the basis of the weighted average number of common shares outstanding during each year. Diluted net loss per share is computed similar to basic net loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company uses the “if-converted” method for calculating the earnings per share impact of outstanding convertible debentures, whereby the securities are assumed converted and an earnings per incremental share is computed. Options, warrants and their equivalents are included in earnings per share calculations through the treasury stock method. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. In addition, there were no vested restricted stock for periods presented. Potentially dilutive securities excluded from the basic and diluted net income per share are as follows: <p id="xdx_89C_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zCaICQgqias9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> SCHEDULE OF ANTI-DILUTIVE WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260101__20260630_zyP2SxirQAl1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20250101__20250630_zuGSrJlGu97k" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zgYacvgbXBS4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Convertible debt</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">977,041,667</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">1,018,265,762</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsToPurchaseCommonStockMember_zJDPCCtkFov3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants to purchase common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,955,770</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,756,977</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--IncentiveSharesPayableIssuedWithNonConvertibleNotesMember_zDC9tBAZtFyi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Incentive shares payable issued with non convertible notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,322,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,271,875</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zrQFc6N96Gei" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Restricted stock awards</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,974,375</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_z645rwyADcD1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,006,319,937</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,043,268,989</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_zDNUGyQ40yVd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="display: none; padding-bottom: 2.5pt">Anti-dilutive securities</td><td style="display: none; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right">1,006,319,937</td><td style="display: none; padding-bottom: 2.5pt; text-align: left"> </td><td style="display: none; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right">1,043,268,989</td><td style="display: none; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Stock-based compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the consolidated statements of operations, as if such amounts were paid in cash. Upon exercise of a common stock equivalent, the Company issues new shares of common stock out of its authorized shares. Long-lived assets The Company follows a “primary asset” approach to determine the cash flow estimation period for a group of assets and liabilities that represents the unit of accounting for a long-lived asset to be held and used. Long-lived assets to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. Property and equipment are stated at cost. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings. For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line method over their estimated useful lives of 5 to 15 years. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. Leases In February 2016, the FASB issued ASC 842, Leases, (“ASC 842”) to increase transparency and comparability among organizations by requiring the recognition of right-of-use (ROU) assets and lease liabilities on the balance sheet for leases previously classified as operating leases. The Company adopted ASC 842 effective January 1, 2022, and recognized and measured operating leases existing at, or entered into after, January 1, 2021 (the beginning of the earliest comparative period presented) using a modified retrospective approach, with certain practical expedients available (see Note 4). The Company’s accounting for finance leases under ASC 842 remained unchanged. In accordance with ASC 842, the Company determines if an arrangement is a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent our right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, we estimate incremental borrowing rates corresponding to the reasonably certain lease term. If the estimate of our incremental borrowing rate was changed, our operating lease assets and liabilities could differ materially. Finance leases lease assets and liabilities are recognized at the lease commencement date at the present value of the future lease payments not yet paid using the Company’s incremental borrowing rate, Assets acquired under finance lease are included in property and equipment, while finance lease obligations are included in other current liabilities and other long- term liabilities on the consolidated balance sheets. Income taxes The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse. The Company follows a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Management has evaluated and concluded that there were no material uncertain tax positions requiring recognition in the Company’s consolidated financial statements as of June 30, 2026, or December 31, 2025. The Company does not expect any significant changes in its unrecognized tax benefits within twelve months of the reporting date. Treasury Stock The Company uses the cost method when it purchases its own common stock as treasury shares and displays treasury stock as a reduction of shareholders’ deficit. Fair Value of Financial Instruments Accounting Standards Codification subtopic 825-10, Financial Instruments (“ASC 825-10”) requires disclosure of the fair value of certain financial instruments. ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of non-performance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of input that may be used to measure fair value: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 1 – Quoted prices in active markets for identical assets or liabilities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 2 – Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 3 – Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.</td></tr> </table> To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement. The carrying value of the Company’s cash, accounts receivable, accounts payable, short-term borrowings (including lines of credit and notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity. As of June 30, 2026, and December 31, 2025, the Company did not have any items that would be classified as level 1, 2 or 3 disclosures. Reclassifications Certain reclassifications have been made to prior year data to conform to the current year’s presentation. These reclassifications had no impact on reported loss. Recent accounting pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

Use of estimates The preparation of the financial statements in conformity with U. S. GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates include the recoverability and useful lives of long-lived assets, provision against bad debt, the fair value of the Company’s stock, and stock-based compensation. Actual results may differ from these estimates. For purposes of clarity and ease of presentation, all dollar amounts in these financial statements have been rounded to the nearest whole number. However, the underlying data used in the calculations is not rounded, and the totals presented may differ by a small amount due to rounding. These differences are considered immaterial and do not affect the overall financial position or results of operations.

Revenue Recognition The Company recognizes revenue when: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed or determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management’s judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded.

Patient Service Revenue Our revenues relate to net patient fees received from various payers and patients themselves under contracts in which our performance obligations are to provide services to the patients. Revenues are recorded during the period our obligations to provide services are satisfied. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify payments at amounts less than our standard charges and provide for payments based upon predetermined rates for services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.

Concentrations of credit risk The Company’s financial instruments are exposed to a concentration of customer risk and accounts receivable risk. Occasionally, the Company’s cash and cash equivalents in interest-bearing accounts may exceed FDIC insurance limits. The financial stability of these institutions is periodically reviewed by senior management.

Accounts receivable Accounts receivables are carried at their estimated collectible amounts net of doubtful accounts. The Company analyzes its history and identifies trends for each major payer sources of revenue to estimate the appropriate allowance for doubtful accounts and provision for bad debts. Management regularly reviews data about these major payer sources of revenue in evaluating the sufficiency of the contractual allowances. Patient receivables are accounts receivable from services provided to patients who have third-party coverage. The Company analyzes contractually due amounts and provides a provision for bad debts, if necessary. The Company records a provision for bad debts in the period of service on the basis of past experience or when indications are the patients are unable or unwilling to pay the portion of their bill for which they are responsible. The difference between the standard rates (or the discounted rates if negotiated) and the amounts actually collected after all reasonable collection efforts have been exhausted, is charged off against the allowance for doubtful accounts.

Net loss per share Basic net loss per common share is based upon the weighted-average number of common shares outstanding. Diluted net loss per common share is the same as basic net loss per common share as the inclusion of potentially dilutive common shares would be anti-dilutive. SCHEDULE OF BASIC NET LOSS PER COMMON SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20260101__20260630_zTdDcNCd53ai" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20250101__20250630_zafdiRRjabOj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six months ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zA25MAfd2yIe" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Net loss attributable to First Choice Healthcare Solutions, Inc.</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(8,447,243</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(2,037,329</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Weighted average common shares, basic and dilutive</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">32,958,288</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">32,958,288</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and dilutive loss per common share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.26</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td></tr> </table> Basic net loss per share is computed on the basis of the weighted average number of common shares outstanding during each year. Diluted net loss per share is computed similar to basic net loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company uses the “if-converted” method for calculating the earnings per share impact of outstanding convertible debentures, whereby the securities are assumed converted and an earnings per incremental share is computed. Options, warrants and their equivalents are included in earnings per share calculations through the treasury stock method. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. In addition, there were no vested restricted stock for periods presented. Potentially dilutive securities excluded from the basic and diluted net income per share are as follows: <p id="xdx_89C_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zCaICQgqias9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> SCHEDULE OF ANTI-DILUTIVE WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260101__20260630_zyP2SxirQAl1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20250101__20250630_zuGSrJlGu97k" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zgYacvgbXBS4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Convertible debt</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">977,041,667</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">1,018,265,762</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsToPurchaseCommonStockMember_zJDPCCtkFov3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants to purchase common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,955,770</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,756,977</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--IncentiveSharesPayableIssuedWithNonConvertibleNotesMember_zDC9tBAZtFyi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Incentive shares payable issued with non convertible notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,322,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,271,875</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zrQFc6N96Gei" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Restricted stock awards</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,974,375</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_z645rwyADcD1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,006,319,937</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,043,268,989</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_zDNUGyQ40yVd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="display: none; padding-bottom: 2.5pt">Anti-dilutive securities</td><td style="display: none; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right">1,006,319,937</td><td style="display: none; padding-bottom: 2.5pt; text-align: left"> </td><td style="display: none; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right">1,043,268,989</td><td style="display: none; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Basic net loss per common share is based upon the weighted-average number of common shares outstanding. Diluted net loss per common share is the same as basic net loss per common share as the inclusion of potentially dilutive common shares would be anti-dilutive. SCHEDULE OF BASIC NET LOSS PER COMMON SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20260101__20260630_zTdDcNCd53ai" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20250101__20250630_zafdiRRjabOj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six months ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zA25MAfd2yIe" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Net loss attributable to First Choice Healthcare Solutions, Inc.</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(8,447,243</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(2,037,329</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Weighted average common shares, basic and dilutive</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">32,958,288</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">32,958,288</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and dilutive loss per common share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.26</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td></tr> </table>

-8447243

-2037329

32958288

-0.26

-0.06

<p id="xdx_89C_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zCaICQgqias9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> SCHEDULE OF ANTI-DILUTIVE WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260101__20260630_zyP2SxirQAl1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20250101__20250630_zuGSrJlGu97k" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zgYacvgbXBS4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Convertible debt</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">977,041,667</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">1,018,265,762</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsToPurchaseCommonStockMember_zJDPCCtkFov3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants to purchase common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,955,770</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,756,977</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--IncentiveSharesPayableIssuedWithNonConvertibleNotesMember_zDC9tBAZtFyi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Incentive shares payable issued with non convertible notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,322,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,271,875</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zrQFc6N96Gei" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Restricted stock awards</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,974,375</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_z645rwyADcD1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,006,319,937</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,043,268,989</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_zDNUGyQ40yVd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="display: none; padding-bottom: 2.5pt">Anti-dilutive securities</td><td style="display: none; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right">1,006,319,937</td><td style="display: none; padding-bottom: 2.5pt; text-align: left"> </td><td style="display: none; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right">1,043,268,989</td><td style="display: none; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

977041667

1018265762

21955770

13756977

7322500

3271875

7974375

1006319937

1043268989

1006319937

1043268989

Stock-based compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the consolidated statements of operations, as if such amounts were paid in cash. Upon exercise of a common stock equivalent, the Company issues new shares of common stock out of its authorized shares.

Long-lived assets The Company follows a “primary asset” approach to determine the cash flow estimation period for a group of assets and liabilities that represents the unit of accounting for a long-lived asset to be held and used. Long-lived assets to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. Property and equipment are stated at cost. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings. For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line method over their estimated useful lives of 5 to 15 years. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.

P5Y

P15Y

Leases In February 2016, the FASB issued ASC 842, Leases, (“ASC 842”) to increase transparency and comparability among organizations by requiring the recognition of right-of-use (ROU) assets and lease liabilities on the balance sheet for leases previously classified as operating leases. The Company adopted ASC 842 effective January 1, 2022, and recognized and measured operating leases existing at, or entered into after, January 1, 2021 (the beginning of the earliest comparative period presented) using a modified retrospective approach, with certain practical expedients available (see Note 4). The Company’s accounting for finance leases under ASC 842 remained unchanged. In accordance with ASC 842, the Company determines if an arrangement is a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent our right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, we estimate incremental borrowing rates corresponding to the reasonably certain lease term. If the estimate of our incremental borrowing rate was changed, our operating lease assets and liabilities could differ materially. Finance leases lease assets and liabilities are recognized at the lease commencement date at the present value of the future lease payments not yet paid using the Company’s incremental borrowing rate, Assets acquired under finance lease are included in property and equipment, while finance lease obligations are included in other current liabilities and other long- term liabilities on the consolidated balance sheets.

Income taxes The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse. The Company follows a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Management has evaluated and concluded that there were no material uncertain tax positions requiring recognition in the Company’s consolidated financial statements as of June 30, 2026, or December 31, 2025. The Company does not expect any significant changes in its unrecognized tax benefits within twelve months of the reporting date.

Treasury Stock The Company uses the cost method when it purchases its own common stock as treasury shares and displays treasury stock as a reduction of shareholders’ deficit.

Fair Value of Financial Instruments Accounting Standards Codification subtopic 825-10, Financial Instruments (“ASC 825-10”) requires disclosure of the fair value of certain financial instruments. ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of non-performance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of input that may be used to measure fair value: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 1 – Quoted prices in active markets for identical assets or liabilities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 2 – Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 3 – Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.</td></tr> </table> To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement. The carrying value of the Company’s cash, accounts receivable, accounts payable, short-term borrowings (including lines of credit and notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity. As of June 30, 2026, and December 31, 2025, the Company did not have any items that would be classified as level 1, 2 or 3 disclosures.

Reclassifications Certain reclassifications have been made to prior year data to conform to the current year’s presentation. These reclassifications had no impact on reported loss.

Recent accounting pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

NOTE 3— NOTES PAYABLE Non-Convertible Notes Payable 20% Cash Payment Notes During the years ended December 31, 2022, and December 31, 2021, the Company issued eighteen non-convertible notes payable to individuals for a total face value of $2,076,158. The notes were due within 60 days from the dates of issuance, were interest free, with a 20% cash payment on the principal amount of the note and were unsecured. During the years ended December 31, 2024, and 2023, the Company repaid or refinanced cumulative principal of $1,283,521 and $156,000, respectively. The Company offered, and investors accepted a conversion of their note payable to the Series C Preferred Convertible stock. A total of $2,225,274 inclusive of a 1.35x conversion incentive was converted. The balance of the non-convertible notes payable as of June 30, 2026 and December 31, 2025, was $<span id="xdx_90C_eus-gaap--NotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--NonConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--TwentyPercentageCashPaymentNotesMember_zceCPneoWlMl" title="Notes payable">0 and $<span id="xdx_90A_eus-gaap--NotesPayable_iI_c20251231__us-gaap--LongtermDebtTypeAxis__custom--NonConvertibleNotesPayableMember__us-gaap--AwardTypeAxis__custom--TwentyPercentageCashPaymentNotesMember_zP7WFQ3NEgbj" title="Notes payable">2,965,429, respectively. PPP Loans In 2020, the Company and its two subsidiaries received Paycheck Protection Plan (“PPP”) loans under the Cares Act totaling $1,386,580. The PPP loans were expected to be forgiven by the U.S. Small Business Association (“SBA”) and as such, were not made eligible for any distributions under the amended joint Plan of Reorganization which was approved on February 23, 2021(the “Plan”). The Plan further required the Company to file proper forgiveness applications with the SBA no later than February 19, 2021. The Company successfully filed for and received forgiveness confirmation for one of the PPP loans for $103,618 plus interest. The remaining two PPP loans forgiveness applications were not properly completed and filed. The Company reinitiated the two forgiveness applications with the SBA and during the year ended December 31, 2024, the Company received forgiveness for one PPP loan for $812,324. The Company received confirmation from the SBA of full forgiveness of the final PPP loan of $471,300 April 24, 2025. As of June 30, 2026, the Company does not have any open applications filed with the SBA. Other Non-Convertible Notes As of June 30, 2026, and December 31, 2025, there were $2,141,089 and $1,305,704, respectively, of Other Non-Convertible Notes. The Notes have fixed interest rates that range up to <span id="xdx_907_eus-gaap--LongTermDebtPercentageBearingFixedInterestRate_iI_pid_dp_uPure_c20260630__us-gaap--LongtermDebtTypeAxis__custom--OtherNonConvertibleNotesMember__srt--RangeAxis__srt--MaximumMember_z4mD7BMeI525" title="Fixed interest rates">18%. As of June 30, 2026, the Notes include $<span id="xdx_900_eus-gaap--OtherLiabilitiesCurrent_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--OtherNonConvertibleNotesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RidgecrestCapitalMember_zlV74FGcNZR1" title="Due to related party">1,712,308 due to Ridgecrest Capital, $<span id="xdx_901_eus-gaap--OtherLiabilitiesCurrent_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--OtherNonConvertibleNotesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BeydoggLLCMember_zWGOeozODbhb" title="Due to related party">200,000 due to Beydogg LLC, and $<span id="xdx_909_eus-gaap--OtherLiabilitiesCurrent_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--OtherNonConvertibleNotesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefFinancialOfficerMember_zAaxP7cOnN8j" title="Due to related party">151,858 due to the Company’s prior Chief Financial Officer. The Notes due to Note Payable holders and the prior Chief Financial Officer relate to deferred compensation, payments to third party service providers, and other normal course of business items. As of December 31, 2025, the Notes include $<span id="xdx_906_eus-gaap--NotesPayableCurrent_iI_c20251231__us-gaap--LongtermDebtTypeAxis__custom--OtherNonConvertibleNotesMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zWGkEZLGvSjb">1,153,846 due to Thor Special Situations LLC (a related party to the Company’s Chief Executive Officer) and $<span id="xdx_901_eus-gaap--NotesPayableCurrent_iI_c20251231__us-gaap--LongtermDebtTypeAxis__custom--OtherNonConvertibleNotesMember__srt--TitleOfIndividualAxis__custom--MultipleRelatedPartiesMember_zvE42L8FrG8c">151,858 due to the Company’s prior Chief Financial Officer. The Notes due to Thor Special Situations LLC and the prior Chief Financial Officer relate to deferred compensation, payments to third party service provides, and other normal course of business items. Non-convertible notes payable as of June 30, 2026, and December 31, 2025, are comprised of the following: SCHEDULE OF NON CONVERTIBLE NOTES PAYABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260630_zNZ66WPfim8d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20251231_zO595cgI15R7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_401_ecustom--CashPaymentNotesCurrent_iI_zO47kLWoSKe6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">20% Cash Payment Notes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">2,965,429</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--PaycheckProtectionPlanLoansPayable_iI_zNdUgkUtLMgc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">PPP Loans Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--OtherNonconvertibleNotesCurrent_iI_zC0Q6GoyaGOj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Other Non-Convertible Notes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,141,089</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,305,704</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherNotesPayableCurrent_iNI_di_zxf283IHwDr8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,141,089</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,271,133</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--OtherLongTermNotesPayable_iI_z4bLhdGsoL6b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Fees and discounts are deferred and amortized over the life of the non-convertible note payable. During the six months ended June 30, 2026, and 2025, the Company recognized a total of $<span id="xdx_907_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--OtherNonConvertibleNotesMember_zjSd2EILKic" title="Original issuance debt discounts">0 and $<span id="xdx_90A_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_c20250101__20250630__us-gaap--LongtermDebtTypeAxis__custom--OtherNonConvertibleNotesMember_zXBJetIYHpO1" title="Original issuance debt discounts">0, respectively, from the amortization of original issuance debt discounts. The outstanding balance of debt discount as of June 30, 2026, and December 31, 2025, was $0 and $0, respectively. Convertible Notes Payable 10% OID Senior Secured Convertible Notes <span id="xdx_908_eus-gaap--DebtInstrumentDescription_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementsMember_ztPdT1FQf0ql">The Company entered into Security Purchase Agreements with lenders for the sale of 10% original issue discount senior secured promissory notes (“10% Notes”) and warrants to purchase shares of the Company’s common stock equal to 50% of the face value. The 10% Notes accrue interest at 10% per annum payable quarterly, are convertible into shares of the Company’s common stock at the option of the holder at any time. The conversion price in effect on the conversion date shall be equal to: the lesser of 75% of the price per share of Common Stock paid by other investors for a majority of the Common Stock issued in the qualified financing (as defined under the 10% Notes) or seventy five cents ($0.75), subject to adjustment therein. The 10% Notes have full ratchet and anti-dilution provisions, a principal adjustment provision upon default, providing for a principal increase to 110% at maturity if unpaid, 120% at Nine months if unpaid and 130% at 12 months if unpaid. The 10% Notes were due March 31, 2022, and to date, all default provisions have been waived. The amounts due under the 10% Secured Convertible Notes are secured by assets of the Company pursuant to a security agreement. Warrants to purchase shares of the Company’s common stock have a five-year term, are exercisable upon the completion of a “Qualified Financing” at a cash exercise price equal to the lower of 93.75% of the per share price of Company’s common stock sold to third-party investors in that Qualified Financing, or $0.75 per share, subject to adjustment. The value of the warrants was recorded as debt discounts that are being amortized to interest expense over the life of the notes. At June 30, 2026, the balance of the 10% notes was converted into Series C and Series E preferred stock. Inclusive of a 1.35x conversion incentive, $<span id="xdx_904_eus-gaap--DebtConversionOriginalDebtAmount1_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z5BtYFNRS3s6" title="Debt conversion debt amount">6,921,595 was converted to Series C and $<span id="xdx_90F_eus-gaap--DebtConversionOriginalDebtAmount1_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z7EnTuw3WzUa" title="Debt conversion debt amount">6,398,063 was converted to Series E. At December 31, 2025, the balance of 10% notes was $5,948,250 with accrued interest payable of $3,881,716. 35% OID Super Priority Senior Secured Convertible Notes The Company entered into Security Purchase Agreements with lenders for the sale of 35% original issue discount senior secured promissory notes (“35% Notes”), warrants to purchase shares of the Company’s common and shares of the Company’s common stock as incentives. The 35% Notes have a 35% original issuance discount being amortized to interest expense through maturity, are non-interest bearing, are due at the earlier of six months from the date of issue or upon the occurrence of a liquidity event and are prepayable by the Company at any time at a premium of 120% of the outstanding balance. Upon the occurrence of default, the holder shall have the right, at the holder’s option, to convert the 35% Note in whole or in part, including any outstanding principal amount, interest and any fees and any and all other outstanding amounts owing thereon, in each case, at the lower of 1) 75% of average of the two lowest closing prices of the Company’s common stock during the fifteen (15) consecutive trading days ending on the trading day immediately prior to the applicable conversion; or 2) a 25% discount to lowest share price sold by the Company based on any subsequent financings with other investors. Warrants to purchase shares of the Company’s common stock warrants have a five-year term, are exercisable upon the completion of a Qualified Financing at a cash exercise price equal to 93.75% of the per share price of the Company’s common stock sold to third-party investors in a Qualified Financing. At June 30, 2026, the balance of the 35% notes was converted into Series C and Series E preferred stock. Inclusive of a 1.35x conversion incentive, $<span id="xdx_90B_eus-gaap--DebtConversionOriginalDebtAmount1_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z42EUWUjJGj7" title="Debt conversion debt amount">11,183,103 was converted to Series C and $<span id="xdx_909_eus-gaap--DebtConversionOriginalDebtAmount1_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z6997IyYHFVf" title="Debt conversion debt amount">8,296,890 was converted to Series E, At December 31, 2025, the balance of 35% notes was $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20251231__us-gaap--LongtermDebtTypeAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_ztgu0xG3peu4" title="Debt outstanding">10,447,244 with accrued interest payable of $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--LongtermDebtTypeAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zRHJCZ3AIz0c" title="Interest payable">3,451,312. The original issuance discount, deferred financing costs and the relative fair value of the warrants and incentive shares are being amortized to interest expense through maturity. During the six months ended June 30, 2026, and 2025, the Company recognized $<span id="xdx_90C_ecustom--InterestExpenseFromAmortization_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zT4bYkA4e5H2" title="Interest expense from amortization">0 and $<span id="xdx_90C_ecustom--InterestExpenseFromAmortization_c20250101__20250630__us-gaap--LongtermDebtTypeAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zgcp1dgGN6Oa" title="Interest expense from amortization">0 in interest expense from the amortization of original issuance discounts, $<span id="xdx_90E_ecustom--InterestExpenseAmortizationOfDebtDiscountsFromWarrants_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zhzemQrIwO12" title="Interest expense amortization of debt discounts from warrants">0 and $<span id="xdx_901_ecustom--InterestExpenseAmortizationOfDebtDiscountsFromWarrants_c20250101__20250630__us-gaap--LongtermDebtTypeAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zANGmf0Uhgp7" title="Interest expense amortization of debt discounts from warrants">0 in interest expense from the amortization of debt discounts from warrants and $<span id="xdx_907_ecustom--AmortizationOfIncentiveShares_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zeKXX5EpaEo4" title="Amortization of incentive shares">0 and $<span id="xdx_90B_ecustom--AmortizationOfIncentiveShares_c20250101__20250630__us-gaap--LongtermDebtTypeAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zOyZTBsqPFsb" title="Amortization of incentive shares">0 in amortization of incentive shares, respectively. 20% OID Senior Secured Convertible Notes Payable <span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zWjrbHJ0CPd8" title="Debt instrument description">The Company entered into Security Purchase Agreements with lenders for the sale of 20% original issue discount promissory notes (“20% Notes”), warrants to purchase shares of the Company’s common stock with a five-year term, exercisable at any time at the option of the holder at a cash exercise price equal to 85% of the per share price of Company’s common stock sold to third-party investors in a qualified financing and incentive shares of the Company’s common stock. The 20% Notes accrue interest at 10% per annum, principal and interest are due at the earlier of six months from the date of issue or upon the occurrence of a liquidity event. <span id="xdx_908_ecustom--WarrantsExercisableDescription_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zNF2nVLb7O37" title="Warrants exercisable description">The holder shall have the right to convert the principal amount of the 20% Note and any accrued interest into Common Stock (i) on a qualified financing at a price equal to 85% of the qualified offering price; or (i) otherwise at a conversion price equal to: a 10% discount to the VWAP for the five days preceding the date of conversion subject to a maximum price of $1.00, subject to adjustment therein. The 20% OID Notes are not convertible into shares of Series C Preferred Stock of the Company. At June 30, 2026, and December 31, 2025, the balance of 20% Notes was $<span id="xdx_90A_eus-gaap--DebtInstrumentCarryingAmount_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_ztWODA6S8sq4" title="Debt outstanding">2,913,750 and $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20251231__us-gaap--LongtermDebtTypeAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_z33NZOfUWg0e" title="Debt outstanding">3,573,750 respectively, with accrued interest payable of $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zWL1fu6TGZdf" title="Interest payable">603,674 and $<span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--LongtermDebtTypeAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zD9vC3ODaovf" title="Interest payable">703,749, respectively. In addition, $<span id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableOneMember_z0pyIbK6PLa1" title="Debt outstanding">622,500 of the 20% OID Senior Secured Convertible Note Payable along with $<span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--LongtermDebtTypeAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableOneMember_zYUECh9D7ON8" title="Interest payable">115,221 in accrued interest for a total of $<span id="xdx_900_eus-gaap--DebtConversionOriginalDebtAmount1_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zaBNPXo0DvSb" title="Debt conversion debt amount">737,721 converted to the Series E. The original issuance discount, relative fair value of the warrants and incentive shares are being amortized to interest expense through maturity. During the six months ended June 30, 2026, the Company recognized $0 in interest expense from the amortization of original issuance discounts of the 20% Notes and $0 in amortization of incentive shares and $0 in accrued interest on the 20% Notes. Convertible notes payable as of June 30, 2026, and December 31, 2025, were comprised of the following: SCHEDULE OF CONVERTIBLE NOTES PAYABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20260630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z0v2rIEP2TEh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zHJu9Q50N2Ye" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_404_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zq91vNsHGhP3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">10% OID Senior Convertible Notes Payable, past due, interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260630__us-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zhTozcijVQkf" title="Interest rate"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zdkhqDIF9VA4" title="Interest rate">10%, secured by assets, convertible at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--SharePrice_iI_pid_c20260630__us-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zJHTFgkT53lk" title="Share price"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20251231__us-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zCtvx9XidTsh" title="Share price">0.75 per share</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,948,250</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSeniorSecuredConvertibleNotesMember_zTin8mLBzSo" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">35% OID Super Priority Senior Convertible Notes Payable, due in <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--DebtInstrumentTerm_dtY_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zbvHaBg9AsEi" title="Debt instrument, term"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--DebtInstrumentTerm_dtY_c20250101__20251231__us-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zlnNSVgzsMc" title="Debt instrument, term">2 years from date of issuance, interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260630__us-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zl2GwKTlnhEa"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zyyCPhJsgxOa">35%, secured by assets, convertible upon qualifying financing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,447,244</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesMember_zpSyJesAHe5b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">20% OID Senior Convertible Notes Payable, past due, interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260630__us-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zNS7Yq3bynI5" title="Interest rate"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20251231__us-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zW0MOcbXzxxh" title="Interest rate">10%, secured by assets, convertible at max $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20260630__us-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zS2cRkRsWJLh" title="Share price"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--SharePrice_iI_pid_c20251231__us-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zzoLILODObmi" title="Share price">1.00 per share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,517,424</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,573,750</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--ConvertibleNotesPayableGross_iI_maCNPzfIf_maCNPz2wX_z26MjaPaWWAb" style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,517,424</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,969,244</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ConvertibleNotesPayableUnamortizedDiscounts_iNI_di_msCNPzfIf_msCNPz2wX_zTOQHcd88gV6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: unamortized discounts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iTI_mtCNPzfIf_zK09fpOKcLqd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,517,424</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">19,969,244</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ConvertibleNotesPayableCurrent_iNI_di_zNKO9dr4saIf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,517,424</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(19,969,244</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--ConvertibleLongTermNotesPayable_iI_zLpXgnB7OqHa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Long-term portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>

2076158

1283521

156000

2225274

2965429

1386580

103618

812324

471300

2141089

1305704

0.18

1712308

200000

151858

1153846

151858

Non-convertible notes payable as of June 30, 2026, and December 31, 2025, are comprised of the following: SCHEDULE OF NON CONVERTIBLE NOTES PAYABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260630_zNZ66WPfim8d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20251231_zO595cgI15R7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_401_ecustom--CashPaymentNotesCurrent_iI_zO47kLWoSKe6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">20% Cash Payment Notes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">2,965,429</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--PaycheckProtectionPlanLoansPayable_iI_zNdUgkUtLMgc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">PPP Loans Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--OtherNonconvertibleNotesCurrent_iI_zC0Q6GoyaGOj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Other Non-Convertible Notes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,141,089</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,305,704</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherNotesPayableCurrent_iNI_di_zxf283IHwDr8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,141,089</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,271,133</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--OtherLongTermNotesPayable_iI_z4bLhdGsoL6b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

2965429 2141089 1305704

2141089

4271133

The Company entered into Security Purchase Agreements with lenders for the sale of 10% original issue discount senior secured promissory notes (“10% Notes”) and warrants to purchase shares of the Company’s common stock equal to 50% of the face value. The 10% Notes accrue interest at 10% per annum payable quarterly, are convertible into shares of the Company’s common stock at the option of the holder at any time. The conversion price in effect on the conversion date shall be equal to: the lesser of 75% of the price per share of Common Stock paid by other investors for a majority of the Common Stock issued in the qualified financing (as defined under the 10% Notes) or seventy five cents ($0.75), subject to adjustment therein.

The 10% Notes have full ratchet and anti-dilution provisions, a principal adjustment provision upon default, providing for a principal increase to 110% at maturity if unpaid, 120% at Nine months if unpaid and 130% at 12 months if unpaid. The 10% Notes were due March 31, 2022, and to date, all default provisions have been waived. The amounts due under the 10% Secured Convertible Notes are secured by assets of the Company pursuant to a security agreement.

Warrants to purchase shares of the Company’s common stock have a five-year term, are exercisable upon the completion of a “Qualified Financing” at a cash exercise price equal to the lower of 93.75% of the per share price of Company’s common stock sold to third-party investors in that Qualified Financing, or $0.75 per share, subject to adjustment. The value of the warrants was recorded as debt discounts that are being amortized to interest expense over the life of the notes.

6921595

6398063

5948250

3881716

The Company entered into Security Purchase Agreements with lenders for the sale of 35% original issue discount senior secured promissory notes (“35% Notes”), warrants to purchase shares of the Company’s common and shares of the Company’s common stock as incentives. The 35% Notes have a 35% original issuance discount being amortized to interest expense through maturity, are non-interest bearing, are due at the earlier of six months from the date of issue or upon the occurrence of a liquidity event and are prepayable by the Company at any time at a premium of 120% of the outstanding balance. Upon the occurrence of default, the holder shall have the right, at the holder’s option, to convert the 35% Note in whole or in part, including any outstanding principal amount, interest and any fees and any and all other outstanding amounts owing thereon, in each case, at the lower of 1) 75% of average of the two lowest closing prices of the Company’s common stock during the fifteen (15) consecutive trading days ending on the trading day immediately prior to the applicable conversion; or 2) a 25% discount to lowest share price sold by the Company based on any subsequent financings with other investors.

Warrants to purchase shares of the Company’s common stock warrants have a five-year term, are exercisable upon the completion of a Qualified Financing at a cash exercise price equal to 93.75% of the per share price of the Company’s common stock sold to third-party investors in a Qualified Financing.

11183103

8296890

10447244

3451312

0 0 0 0 0 0

The Company entered into Security Purchase Agreements with lenders for the sale of 20% original issue discount promissory notes (“20% Notes”), warrants to purchase shares of the Company’s common stock with a five-year term, exercisable at any time at the option of the holder at a cash exercise price equal to 85% of the per share price of Company’s common stock sold to third-party investors in a qualified financing and incentive shares of the Company’s common stock. The 20% Notes accrue interest at 10% per annum, principal and interest are due at the earlier of six months from the date of issue or upon the occurrence of a liquidity event.

The holder shall have the right to convert the principal amount of the 20% Note and any accrued interest into Common Stock (i) on a qualified financing at a price equal to 85% of the qualified offering price; or (i) otherwise at a conversion price equal to: a 10% discount to the VWAP for the five days preceding the date of conversion subject to a maximum price of $1.00, subject to adjustment therein. The 20% OID Notes are not convertible into shares of Series C Preferred Stock of the Company.

2913750

3573750

603674

703749

622500

115221

737721

0 0 0

Convertible notes payable as of June 30, 2026, and December 31, 2025, were comprised of the following: SCHEDULE OF CONVERTIBLE NOTES PAYABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20260630__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z0v2rIEP2TEh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20251231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zHJu9Q50N2Ye" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_404_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zq91vNsHGhP3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">10% OID Senior Convertible Notes Payable, past due, interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260630__us-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zhTozcijVQkf" title="Interest rate"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zdkhqDIF9VA4" title="Interest rate">10%, secured by assets, convertible at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--SharePrice_iI_pid_c20260630__us-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zJHTFgkT53lk" title="Share price"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20251231__us-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zCtvx9XidTsh" title="Share price">0.75 per share</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,948,250</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSeniorSecuredConvertibleNotesMember_zTin8mLBzSo" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">35% OID Super Priority Senior Convertible Notes Payable, due in <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--DebtInstrumentTerm_dtY_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zbvHaBg9AsEi" title="Debt instrument, term"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--DebtInstrumentTerm_dtY_c20250101__20251231__us-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zlnNSVgzsMc" title="Debt instrument, term">2 years from date of issuance, interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260630__us-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zl2GwKTlnhEa"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zyyCPhJsgxOa">35%, secured by assets, convertible upon qualifying financing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,447,244</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesMember_zpSyJesAHe5b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">20% OID Senior Convertible Notes Payable, past due, interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260630__us-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zNS7Yq3bynI5" title="Interest rate"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20251231__us-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zW0MOcbXzxxh" title="Interest rate">10%, secured by assets, convertible at max $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20260630__us-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zS2cRkRsWJLh" title="Share price"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--SharePrice_iI_pid_c20251231__us-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zzoLILODObmi" title="Share price">1.00 per share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,517,424</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,573,750</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--ConvertibleNotesPayableGross_iI_maCNPzfIf_maCNPz2wX_z26MjaPaWWAb" style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,517,424</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,969,244</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ConvertibleNotesPayableUnamortizedDiscounts_iNI_di_msCNPzfIf_msCNPz2wX_zTOQHcd88gV6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: unamortized discounts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iTI_mtCNPzfIf_zK09fpOKcLqd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,517,424</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">19,969,244</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ConvertibleNotesPayableCurrent_iNI_di_zNKO9dr4saIf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,517,424</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(19,969,244</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--ConvertibleLongTermNotesPayable_iI_zLpXgnB7OqHa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Long-term portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>

0.10

0.75

5948250

P2Y

0.35

10447244

0.10

1.00

3517424 3573750 3517424 19969244

3517424

19969244

3517424

19969244

NOTE 4— LEASES Operating Leases As a result of the adoption of ASC 842 on January 1, 2021, the Company recognized a lease liability which represents the present value of the remaining operating lease payments discounted using our incremental borrowing rate of 5.0%, and a right-of-use asset. Operating leases consist of an office and clinic locations and have remaining terms of approximately 7 and <span id="xdx_90C_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20210101__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ClinicFacilityMember_zORfZAsKj4pk" title="Lease remaining lease term">1 years, respectively, and include options to extend the leases for additional periods. Generally, the lease term is the minimum of the noncancelable period of the lease or the lease term inclusive of reasonably certain renewal periods. If the estimate of our reasonably certain lease term was changed, our depreciation and rent expense could differ materially. The Company successfully negotiated a termination of the leases. Effective June 30, 2026, has no lease liability related to the office and clinic locations. On August 1, 2024, the Company entered into a lease of a clinic facility sixty-six-month 66 triple-net lease agreement, to expire in 2029. The Company has one option to renew the lease for a five-year 5 period on the same terms and conditions with fair market value rent increases. The Company successfully negotiated a termination of the lease. Effective June 30, 2026, no lease liability exists. On September 1, 2024, the Company entered into a lease of a clinic facility six-year <span id="xdx_900_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20240901__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ClinicFacilityMember_z5AIKuZmnZ7c" style="display: none" title="Lease term">6 triple-net lease agreement, to expire in 2030. The Company has one option to renew the lease for a five-year <span id="xdx_909_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dtY_c20240901__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ClinicFacilityMember_zhxOhNZ5pg4g" style="display: none" title="Lease renewal term">5 period on the same terms and conditions with annual rent increases. The Company successfully negotiated a termination of the lease. Effective June 30, 2026, no lease liability exists. SCHEDULE OF TERMINATION OF THE LEASE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20260630__srt--TitleOfIndividualAxis__custom--FirstChoiceMedicalGroupMember_zAXOBe0cdWle" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260630__srt--TitleOfIndividualAxis__custom--TheGoodClinicMember_zeen98VuBB0a" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260630__srt--TitleOfIndividualAxis__custom--FirstChoiceHealthcareSolutionsConsolidatedMember_zhotJc2q9Hm6" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">First Choice Medical Group</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">The Good Clinic</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">First Choice Healthcare Solutions Consolidated</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_iI_ztyaokSrFUZ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; text-indent: 0pt; padding-left: 0pt">RTU Asset</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,151,460</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,628,964</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,780,424</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FinanceLeaseRightOfUseAssetAccumulatedAmortization_iNI_di_zty3RSQhhNIf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 0pt">RTU Accumulated Depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,368,349</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(689,885</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,058,234</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--FinanceLeaseRightOfUseAsset_iI_z2aLFKWc44zc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: 0pt; padding-left: 0pt">Net RTU</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">1,783,111</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">939,079</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,722,191</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FinanceLeaseLiability_iI_zSP5zGQcqtw3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">LT Lease Liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,569,919</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">721,336</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,291,256</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ShortTermLeaseLiability_zSdizHwJmhG9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 0pt">ST Lease Liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">338,108</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">46,587</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">384,696</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--NetLeaseLiability_iI_zeAoLHzXKty4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: 0pt; padding-left: 0pt">Net Lease Liability</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">1,908,028</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">767,924</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,675,951</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: 0pt; padding-left: 0pt">Gain / (Loss) from RTU less Liability</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">124,917</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(171,156</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(46,239</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--SurrenderedDeposits_iI_zvF3Whuz4e7f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Surrendered deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(93,739</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21,570</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(115,308</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--NetGainFromLeaseTermination_iI_z4X2HcIr1Jb6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: 0pt; padding-left: 0pt">Net Gain from lease termination</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">31,178</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(192,726</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(161,548</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--NegotiatedSettlement_iI_zKC61mk53jgb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Negotiated Settlement (Net of outstanding AP)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(46,527</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(46,527</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--ReliefOfAccountsPayable_iI_zYDNaLbzBJki" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 0pt; padding-left: 0pt">Relief of Accounts Payable @ June 30</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,507,450</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,507,450</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--TotalGainRelatedToLease_iI_z8v3XHBOOVh1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Total Gain related to Lease and AP Liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,538,628</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(239,253</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,299,375</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--ConversionOfAccountsPayable_zIl0g1JaM0a7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Conversion of Accounts Payable & Net RTU Gain to Series C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,000,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--GainLossOnTerminationLease_iI_zKkA8Y7xkcT3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: 0pt; padding-left: 0pt">Gain / (Loss) on Lease Termination</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">538,628</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(239,253</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">299,375</td><td style="font-weight: bold; text-align: left"> </td></tr> </table> Sale/Leaseback On March 31, 2016, the Company entered into a lease of Marina Towers under a sale/leaseback transaction, via a 10-year absolute triple-net master lease agreement, to expire in 2026. The Company has two successive options to renew the lease for five-year periods on the same terms and conditions and did not have any residual interest or the option to repurchase the facility at the end of the lease term. During October 2021, the Company, through the eighteenth judicial circuit court in Brevard County, Florda, received an order approving joint stipulation for alternative resolution to the Company’s real estate lease in Melbourne, Florida. The order terminated the Company’s use of floors three and four of the building immediately, while terminating its right to possession and use of floors three and five at December 31, 2021. The order also terminated the existing lease payment schedule, replacing it with the following: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Payment of $50,000 on October 12, 2021</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The following rent installment payments:</td></tr> </table> SCHEDULE OF RENT INSTALLMENT PAYMENTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">I.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$200,000 by October 19, 2021</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">II.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$250,000 by November 15, 2021</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">III.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$306,166 by December 15, 2021</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">IV.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$275,000 by January 7, 2022</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">V.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$31,166 by January 15, 2022</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">VI.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$300,000 by February 8, 2022</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">VII.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$31,166 by February 15, 2022</td></tr> </table> Upon receipt of the Order, the Company recorded a liability and lease settlement expense for the amount of the order, or $1,443,498. As of December 31, 2023, the Company had paid $243,498 of this obligation and continues to carry a remaining open accounts payable liability of approximately $1,200,000. The Company is working to reach a settlement with the landlord. Finance Leases The Company adopted ASC 842 on January 1, 2021. On May 31, 2018, the Company entered into a lease agreement for the use of equipment with 60 monthly payments of $2,112 payable through April 2023 with an effective interest rate of 5.00% per annum. The Company failed to make all payments as required under the lease agreement which resulted in the lender filing a complaint in the County Court of Brevard County, Florida (“Court”). In June 2023 the Court issued an order to the Company to return the equipment. The Company has accrued $19,473 to cover final payment and subsequently has reached an agreement to settle this debt for $9,000.

0.050

P7Y

P1Y

P66M

P5Y

P6Y

P5Y

SCHEDULE OF TERMINATION OF THE LEASE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20260630__srt--TitleOfIndividualAxis__custom--FirstChoiceMedicalGroupMember_zAXOBe0cdWle" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260630__srt--TitleOfIndividualAxis__custom--TheGoodClinicMember_zeen98VuBB0a" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260630__srt--TitleOfIndividualAxis__custom--FirstChoiceHealthcareSolutionsConsolidatedMember_zhotJc2q9Hm6" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">First Choice Medical Group</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">The Good Clinic</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">First Choice Healthcare Solutions Consolidated</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_iI_ztyaokSrFUZ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; text-indent: 0pt; padding-left: 0pt">RTU Asset</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,151,460</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,628,964</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,780,424</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FinanceLeaseRightOfUseAssetAccumulatedAmortization_iNI_di_zty3RSQhhNIf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 0pt">RTU Accumulated Depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,368,349</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(689,885</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,058,234</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--FinanceLeaseRightOfUseAsset_iI_z2aLFKWc44zc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: 0pt; padding-left: 0pt">Net RTU</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">1,783,111</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">939,079</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,722,191</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FinanceLeaseLiability_iI_zSP5zGQcqtw3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">LT Lease Liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,569,919</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">721,336</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,291,256</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ShortTermLeaseLiability_zSdizHwJmhG9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 0pt">ST Lease Liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">338,108</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">46,587</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">384,696</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--NetLeaseLiability_iI_zeAoLHzXKty4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: 0pt; padding-left: 0pt">Net Lease Liability</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">1,908,028</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">767,924</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,675,951</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: 0pt; padding-left: 0pt">Gain / (Loss) from RTU less Liability</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">124,917</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(171,156</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(46,239</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--SurrenderedDeposits_iI_zvF3Whuz4e7f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Surrendered deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(93,739</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21,570</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(115,308</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--NetGainFromLeaseTermination_iI_z4X2HcIr1Jb6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: 0pt; padding-left: 0pt">Net Gain from lease termination</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">31,178</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(192,726</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(161,548</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--NegotiatedSettlement_iI_zKC61mk53jgb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Negotiated Settlement (Net of outstanding AP)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(46,527</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(46,527</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--ReliefOfAccountsPayable_iI_zYDNaLbzBJki" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 0pt; padding-left: 0pt">Relief of Accounts Payable @ June 30</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,507,450</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,507,450</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--TotalGainRelatedToLease_iI_z8v3XHBOOVh1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Total Gain related to Lease and AP Liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,538,628</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(239,253</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,299,375</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--ConversionOfAccountsPayable_zIl0g1JaM0a7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Conversion of Accounts Payable & Net RTU Gain to Series C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,000,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--GainLossOnTerminationLease_iI_zKkA8Y7xkcT3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: 0pt; padding-left: 0pt">Gain / (Loss) on Lease Termination</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">538,628</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(239,253</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">299,375</td><td style="font-weight: bold; text-align: left"> </td></tr> </table>

3151460

1628964

4780424

1368349

689885

2058234

1783111

939079

2722191

1569919

721336

2291256

338108 46587 384696 1908028 767924 2675951 -93739 -21570 -115308 31178 -192726 -161548 -46527 -46527 3507450 3507450 3538628 -239253 3299375 -3000000 -3000000 538628 -239253 299375

the Company entered into a lease of Marina Towers under a sale/leaseback transaction, via a 10-year absolute triple-net master lease agreement, to expire in 2026. The Company has two successive options to renew the lease for five-year periods on the same terms and conditions and did not have any residual interest or the option to repurchase the facility at the end of the lease term.

50000

SCHEDULE OF RENT INSTALLMENT PAYMENTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">I.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$200,000 by October 19, 2021</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">II.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$250,000 by November 15, 2021</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">III.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$306,166 by December 15, 2021</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">IV.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$275,000 by January 7, 2022</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">V.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$31,166 by January 15, 2022</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">VI.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$300,000 by February 8, 2022</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">VII.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$31,166 by February 15, 2022</td></tr> </table>

200000

250000

306166

275000

31166

300000

31166

1443498

243498

1200000

2112

0.0500

19473

9000

NOTE 5 — CAPITAL STOCK The Company has 100,000,000 shares of Common Stock, par value $0.001 per share, authorized for issuance, 1,000,000 shares of Preferred Stock, of which (i) <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesBPreferredConvertibleStockMember_zFHekfM8XnTl" title="Preferred stock, shares authorized">40,000 Preferred shares were allocated to the Series B Convertible Preferred Stock, par value $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesBPreferredConvertibleStockMember_zvEYWNpC0ygc" title="Preferred stock, par value">0.01 per share, (ii) <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesASuperVotingPreferredStockMember_zgUk0Eqh69L6" title="Preferred stock, shares authorized">4 Preferred shares were allocated to the Series A Super Voting Preferred Stock, par value $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesASuperVotingPreferredStockMember_zbGbfmftVn29" title="Preferred stock, par value">0.10 per share and (iii) <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zgFEe1qXm3o2" title="Preferred stock, shares authorized">50,000 Preferred shares were allocated to Series C Preferred Stock, par value $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zv3rH7dS8sRe" title="Preferred stock, par value">0.0001 per share, authorized for issuance. As of June 30, 2026, there were 32,958,288 shares of Common Stock, <span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_ztmG1kcH1t5l" title="Preferred stock, shares outstanding">147 shares of Series B 10% Convertible Preferred Stock, <span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesASuperVotingPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zQ70TZDy9cM6" title="Preferred stock, shares outstanding">4 shares of Series A Super Voting Preferred Stock, and <span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zFtrkOYSJjB4" title="Preferred stock, shares outstanding">0 shares of Series C Convertible Preferred Stock that are issued and outstanding. Series A Super Voting Preferred Stock <span id="xdx_903_eus-gaap--PreferredStockVotingRights_pid_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesASuperVotingPreferredStockMember_zypStE850ndb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders of the Series A Super Voting Preferred Stock shall be entitled to vote on all matters subject to a vote or written consent of the holders of the Company’s Common Stock, and on all such matters, the four (4) shares of Series A Super Voting Preferred Stock shall be entitled to that number of votes equal to the number of votes that all issued and outstanding shares of the Common Stock and all other voting securities of the Company are entitled to, as of any such date of determination, plus one million (1,000,000) votes, it being the intention that the holders of the Series A Super Voting Preferred Stock shall have effective voting control of the Company, on a fully diluted voting basis. Accordingly, each share of Series A Super Voting Stock shall entitle the Holder to that number of votes as is equal to 12.5% of the outstanding shares of Common Stock and all other voting securities of the Company are entitled to, as of such date of determination, plus 250,000 votes. The holders of the Series A Super Voting Preferred Stock shall vote together with the holders of Common Stock as a single class. Currently, Lance Friedman, the Company’s Chief Executive Officer, holds all 4 outstanding shares of the Series A Super Voting Preferred Stock. Series B Preferred Convertible Stock The Company is authorized to issue <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesBPreferredConvertibleStockMember_zbvjK8HJEY61" title="Preferred stock, shares authorized">40,000 shares, $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesBPreferredConvertibleStockMember_zUKSpFgkN1Pg" title="Preferred stock, par value">0.01 par value Series B preferred stock. Each share of the Series B preferred stock is convertible into <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBPreferredConvertibleStockMember_zlSeaSXCSQwe" title="Convertible securities">10,000 shares of common stock in the Company. The Series B 10% Convertible Preferred Stock shall have a <span id="xdx_90F_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesBTenPercentageConvertiblePreferredStockMember_z3QE4AYjvMLb" title="Dividend rate">10% dividend rate and have preference in liquidation so that holders of Series B 10% Convertible Preferred Stock are paid in full prior to any payments to holders of common stock of the Company. The Series B 10% Convertible Preferred Stock shall be automatically converted into shares of common stock of the Company on the effective date of the Corporation’s S-1 filing with the Securities Exchange Commission. In the second quarter of 2022, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z5h6pOizWHyj" title="Number of share issued">141 shares of Series B preferred stock with a par value of $0.01 per share and a purchase price of $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FifteenInvestorsMember_z47RBYtWMjf6" title="Share price">6,750 per share to 15 investors for $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FifteenInvestorsMember_zGIocq6U2Vzb" title="Value of shares issued">1,057,200 which includes a 10% discount of $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z1XgUiFKSME2" title="Debt instrument, unamortized discount">105,450 and cash of $951,750. The terms of these Series B issuances included a 10% share price discount and a 10% dividend. The Company paid $53,994 in fees to brokers related to these issuances. In the second quarter of 2023, the Company sold <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--SeriesBTenPercentageConvertiblePreferredStockMember_zjMRsEWM2n25" title="Sale of stock">6 shares of Series B, 10% convertible preferred stock, with a par value of $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20230630__us-gaap--StatementClassOfStockAxis__custom--SeriesBTenPercentageConvertiblePreferredStockMember_zVS8s7UVNXA9" title="Preferred stock, par value">0.01 per share and a purchase price of $<span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20230630__us-gaap--StatementClassOfStockAxis__custom--SeriesBTenPercentageConvertiblePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneInvestorMember_zPkLyCs6A574" title="Share price">7,500 per share to 1 investor for $<span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--SeriesBTenPercentageConvertiblePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneInvestorMember_zBGAosSiN1Hi" title="Sale of stock consideration received">50,000 which includes a <span id="xdx_906_ecustom--PreferredStockDiscountRatePercentage_pid_dp_uPure_c20230401__20230630__us-gaap--StatementClassOfStockAxis__custom--SeriesBTenPercentageConvertiblePreferredStockMember_zJ7cY9fN6sPi" title="Discount rate">10% discount of $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20230630__us-gaap--StatementClassOfStockAxis__custom--SeriesBTenPercentageConvertiblePreferredStockMember_z3wPkoTiiFvb" title="Debt instrument, unamortized discount">5,000 and cash of $45,000. The Company paid $0 in fees to brokers related to these issuances. As of June 30, 2026, and December 31, 2025, the total Series B preferred shares outstanding were <span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zsNSku1a6Rp9">147 and <span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z1yD9QpxtCk4" title="Preferred stock, shares outstanding">147 shares, respectively. Series C Preferred Convertible Stock The Company is authorized to issue up to <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPreferredConvertibleStockMember_zJUcZJlFqPph" title="Preferred stock, shares authorized">56,000 shares, $<span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPreferredConvertibleStockMember_z15lluRV2Ys8" title="Preferred stock, par value">0.01 par value Series C preferred stock. Effective May 7, 2026, the Company converted certain outstanding debt and convertible securities into Series C Preferred Stock. The converted instruments included the 10% OID Senior Secured Convertible Promissory Note, 35% OID Super Priority Convertible Promissory Note, Equity Plus Bonus debt instrument, and 10% Series B Convertible Stock. Debt Conversion was in the amount of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPreferredConvertibleStockMember_zGiItv7zzQNg" title="Debt conversion amount">22,242,837 in exchange for <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPreferredConvertibleStockMember_zwQF4nQom7Gd" title="Debt conversion shares">22,243 shares of Series C Preferred Stock. In addition, the warrants that were attached to the instruments below in the amount of <span id="xdx_904_ecustom--ClassOfWarrantOrRightOutstandingExchanged_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPreferredConvertibleStockMember_z406evmcODIc" title="Warrants shares exchanged">9,116,573 where exchanged for new five (5) year warrants in the amount of 11,181,419. The instruments and lease debt converted into Series C Preferred Stock included: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">10% OID Senior Secured Convertible Promissory Note with Warrant;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">35% OID Super Priority Convertible Promissory Note with Warrant;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Equity Plus Bonus debt instrument with Warrant; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">10% Series B Convertible Stock and Warrant.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Termination of Leases and all lease debt.</td></tr></table> Series E Preferred Convertible Stock Effective June 30, 2026, the Company entered into an Exchange agreement providing for the issuance of Series E Preferred Stock. The principal terms of the Series E Preferred Stock are as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Dividend: The Series E Preferred Stock bears a <span id="xdx_900_eus-gaap--PreferredStockDividendRatePercentage_dp_uPure_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesEPreferredConvertibleStockMember_zgUILvlypdXe" title="Dividend rate percentage">15% dividend, payable either in cash or through payment-in-kind (“PIK”), as permitted under the governing terms.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Conversion Restriction: The Series E Preferred Stock is not convertible during the first 12 months following issuance.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Conversion Price: Beginning on the 12-month anniversary, the Series E Preferred Stock becomes convertible at a variable conversion price equal to a <span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionRatio1_dp_uPure_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesEPreferredConvertibleStockMember_zFIrE4u1eCwi" title="Conversion price">20% discount to the lowest closing price of the Company’s common stock during the five trading days used to determine the applicable conversion price.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Most-Favored-Nation Provision: The Series E Preferred Stock includes a most-favored-nation (“MFN”) provision permitting the holder, subject to the governing documents, to elect to amend the Series E terms to incorporate more favorable economic terms subsequently granted by the Company in a future financing transaction.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Initial Floor Price: Upon the 12-month anniversary, when the Series E Preferred Stock first becomes convertible, a Floor Price will be established at an <span id="xdx_902_ecustom--PreferredStockDiscountRatePercentage_dp_uPure_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesEPreferredConvertibleStockMember__srt--RangeAxis__srt--MaximumMember_zMMz4yGA0sJ3" title="Discount rate percentage">80% discount to the applicable closing price of the Company’s common stock at that time, meaning the Floor Price will equal <span id="xdx_905_ecustom--PreferredStockDiscountRatePercentage_dp_uPure_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesEPreferredConvertibleStockMember__srt--RangeAxis__srt--MinimumMember_zziU95qPnxwj" title="Discount rate percentage">20% of such closing price.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Floor Price Resets: Following establishment of the initial Floor Price, the Floor Price will be reset every six months thereafter in accordance with the terms of the Series E Certificate of Designation.</td></tr></table> Common stock In the six months ended June 30, 2026, the Company did not issue any shares of its common stock. During the years ended December 31, 2025, and December 31, 2024, the Company did not issue any shares of its common stock. In connection with the issuance of the 35% OID Super Priority Convertible Notes in 2022, the Company was to issue <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--ThirtyFivePercentageOIDSuperPriorityConvertibleNotesTwoThousandTwentyTwoMember_zmMMiE2gzeo3" title="Number of share issued">1,000,000 incentive shares of unrestricted common stock. In connection with the issuance of the 35% OID Super Priority Convertible Notes in 2023, the Company was to issue <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--ThirtyFivePercentageOIDSuperPriorityConvertibleNotesTwoThousandTwentyThreeMember_zghVuNxOAic5" title="Number of share issued">100,000 incentive shares of unrestricted common stock. In connection with the issuance of the 20% OID Convertible Notes in 2023, the Company was to issue <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--TwentyPercentageOIDConvertibleNotesTwoThousandTwentyThreeMember_zXPTiELHVCfd" title="Number of share issued">468,250 incentive shares of unrestricted common stock. As of June 30, 2026, none of the incentive shares were issued and were recorded as a Common share payable current liability.

100000000

0.001

1000000

40000

0.01

0.10

50000

0.0001

32958288

147

The holders of the Series A Super Voting Preferred Stock shall be entitled to vote on all matters subject to a vote or written consent of the holders of the Company’s Common Stock, and on all such matters, the four (4) shares of Series A Super Voting Preferred Stock shall be entitled to that number of votes equal to the number of votes that all issued and outstanding shares of the Common Stock and all other voting securities of the Company are entitled to, as of any such date of determination, plus one million (1,000,000) votes, it being the intention that the holders of the Series A Super Voting Preferred Stock shall have effective voting control of the Company, on a fully diluted voting basis. Accordingly, each share of Series A Super Voting Stock shall entitle the Holder to that number of votes as is equal to 12.5% of the outstanding shares of Common Stock and all other voting securities of the Company are entitled to, as of such date of determination, plus 250,000 votes. The holders of the Series A Super Voting Preferred Stock shall vote together with the holders of Common Stock as a single class. Currently, Lance Friedman, the Company’s Chief Executive Officer, holds all 4 outstanding shares of the Series A Super Voting Preferred Stock.

40000

0.01

10000

0.10

141

0.01

6750

1057200

0.10

105450

951750

0.10

53994

0.01

7500

50000

0.10

5000

45000

147

56000

0.01

22242837

22243

9116573

P5Y

11181419

0.15

0.20

0.80 0.20

1000000

100000

468250

NOTE 6 — STOCK OPTIONS, WARRANTS AND RESTRICTED STOCK UNITS Options The Company does not have an Incentive Stock Plan in place. Restricted Stock Units (“RSU”) All previously issued RSUs were terminated as part of the bankruptcy. No RSUs were issued after the bankruptcy. As such, there are no RSUs outstanding as of June 30, 2026, and December 31, 2025 Warrants Warrants in connection with 10% OID Senior Secured Convertible Notes In connection with the issuance of the 10% Senior Secured Convertible Notes the Company issued warrants. The warrants can only be exercised upon a qualified offering. The warrants have an exercise price equal to<span id="xdx_900_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsPercentage_iI_pid_dp_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zpcUzuCP8Aig"> 93.75% of the price of the qualified offering, subject to a minimum exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember__srt--RangeAxis__srt--MinimumMember_zv815MBbQjl6">1, coverage of <span id="xdx_90B_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsCoveragePercentage_iI_pid_dp_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_znusgr72yNlk">50% and a term of <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zjr061sM6SNc">five years. Effective June 30, 2026, these warrants were exchanged for new Series C warrants. Warrants in connection with 35% OID Super Priority Senior Secured Convertible Notes In connection with the issuance of the 35% Senior Secured Convertible Notes the Company issued warrants. The warrants can only be exercised upon a qualified offering. The warrants have an exercise price equal to <span id="xdx_902_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsPercentage_iI_pid_dp_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zL4fzgcSk41c">93.75% of the price of the qualified offering, subject to a minimum exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember__srt--RangeAxis__srt--MinimumMember_zAhSidtMGrc6">1, coverage of <span id="xdx_90C_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsCoveragePercentage_iI_pid_dp_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zfOPeuOO9bv">50% and a term of <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSuperPrioritySeniorSecuredConvertibleNotesMember_zgwi0uadVcv2">five years. Effective June 30, 2026, these warrants were exchanged for new Series C warrants. Warrants in connection with 20% OID Unsecured Convertible Notes Payable In connection with the issuance of the 20% Unsecured Convertible Notes the Company issued warrants. The warrants have an exercise price equal to <span id="xdx_90A_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsPercentage_iI_pid_dp_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_z5Dhx3sTnPr">85% of the price of the qualified financing price (as defined under the warrant), coverage of <span id="xdx_908_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsCoveragePercentage_iI_pid_dp_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_z8WCp8hbiTld">150% and a term of <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNotesPayableMember_zEc2WfORP0Fj">five years from the date of the warrant. Warrants in connection with Series B Preferred Convertible Stock In connection with the issuance of the Series B Preferred Convertible Stock the Company issued warrants. The warrants can only be exercised upon a qualified offering. The warrants have an exercise price equal to <span id="xdx_90D_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsPercentage_iI_pid_dp_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBPreferredConvertibleStockMember_zz6iuDlFYzJ2">93.75% of the price of the qualified offering, subject to a minimum exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBPreferredConvertibleStockMember__srt--RangeAxis__srt--MinimumMember_zhWixB8mY6W4">1, coverage of <span id="xdx_904_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsCoveragePercentage_iI_pid_dp_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBPreferredConvertibleStockMember_z5qr6XIyHmY8" title="Warrants coverage percentage">50% and a term of <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBPreferredConvertibleStockMember_zXL1QpHqwAmb">five years. Effective June 30, 2026, these warrants were exchanged for new Series C warrants. Warrants in connection with Non-Convertible Notes In connection with the issuance of the Non-Convertible Notes the Company issued warrants. The warrants have an exercise price equal to $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--NonConvertibleNotesMember_zJqtNojAJ1a">0.05 and a term of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--NonConvertibleNotesMember_z3TWx2omP8cg">5 years. Other Warrants issued to Service Providers The Company issued 850,000 warrants to four holders in consideration provided by them to the Company during its restructuring and bankruptcy proceedings. Of these, <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--OneHolderMember__us-gaap--StatementEquityComponentsAxis__custom--OtherWarrantsMember_zl4TnQOYf6B1">200,000 warrants issued to one holder have a term of <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260630__us-gaap--DebtInstrumentAxis__custom--OneHolderMember__us-gaap--StatementEquityComponentsAxis__custom--OtherWarrantsMember_z3mNw5AqkLp1">5 years and an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--OneHolderMember__us-gaap--StatementEquityComponentsAxis__custom--OtherWarrantsMember_z2fM48EVCQqk">0.05, <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--SecondHolderMember__us-gaap--StatementEquityComponentsAxis__custom--OtherWarrantsMember_zJiJc2OP0Jej">350,000 warrants issued to one holder have a term of <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260630__us-gaap--DebtInstrumentAxis__custom--SecondHolderMember__us-gaap--StatementEquityComponentsAxis__custom--OtherWarrantsMember_zIUDeyxmaFDc">5 years and an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--SecondHolderMember__us-gaap--StatementEquityComponentsAxis__custom--OtherWarrantsMember_z4BAEVk8mJHb" title="Exercise price">0.25 and <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--ThirdHolderMember__us-gaap--StatementEquityComponentsAxis__custom--OtherWarrantsMember_zuyyYiGuqYP6">300,000 warrants (<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--TwoSeparateHolderMember__us-gaap--StatementEquityComponentsAxis__custom--OtherWarrantsMember_zK7qnPlD6Bj" title="Number of warrants">150,000 each issued to two separate holders) have a term of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260630__us-gaap--DebtInstrumentAxis__custom--TwoSeparateHolderMember__us-gaap--StatementEquityComponentsAxis__custom--OtherWarrantsMember_zRLZsQ36AoT5" title="Warrants term">5 years and an exercise price of <span id="xdx_905_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsPercentage_iI_pid_dp_c20260630__us-gaap--StatementEquityComponentsAxis__custom--OtherWarrantsMember_zaPmSPbJIgC8" title="Warrants exercise price percentage">93.75% of the next qualifying offering. In addition, the company issued 1,210,000 additional warrants. Warrants in connection with Series C Preferred Stock <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20260101__20261231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zqY1ZT4MlTAf" title="Warrant or Right, Reason for Issuance, Description">In connection with the issuance of the Series C Preferred Stock the Company issued warrants. 1,518,675 warrants from the 10% OID Senior Secured Convertible Promissory Note with Warrant, 2,692,423 warrants from the 35% OID Super Priority Convertible Promissory Note with Warrant, 528,000 from the Series B Preferred Convertible, 3,526,875 warrants from the 20% OID Unsecured Convertible Note Payable and 850,000 warrants from Other Non-Convertible Notes were exchanged for a total of 11,181,419 warrants. Warrants in connection with Series E Preferred Stock In connection with the issuance of the Series E Preferred Stock the Company issued warrants. <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesEPreferredConvertibleStockMember__us-gaap--DebtInstrumentAxis__custom--SeriesETenPercentageConvertiblePreferredStockMember_zNqjx5f2786i" title="Warrants shares issued">1,455,450 warrants from the 10% OID Senior Secured Convertible Promissory Note with Warrant, <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesEPreferredConvertibleStockMember__us-gaap--DebtInstrumentAxis__custom--SeriesEThirtyFivePercentageConvertiblePreferredStockMember_zH4XBxoYSrEc" title="Warrants shares issued">2,531,199 warrants from the 35% OID Super Priority Convertible Promissory Note with Warrant and <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesEPreferredConvertibleStockMember__us-gaap--DebtInstrumentAxis__custom--SeriesETwentyPercentageConvertiblePreferredStockMember_zYVdvrfGZtH1" title="Warrants shares issued">466,875 warrants from the 20% OID Unsecured Convertible Note Payable were exchanged for a total of 7,347,476 warrants. Warrants outstanding as of June 30, 2026, and December 31, 2025. SCHEDULE OF WARRANTS OUTSTANDING <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260630_zU1c0Ixm2Iv6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20251231_z7jnCQN3Syfd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zFtJoUQ6drX6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">10% OID Senior Secured Convertible Notes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">2,974,125</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSeniorSecuredConvertibleNotesMember_z1XCOx10umc5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">35% OID Super Priority Senior Secured Convertible Notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,223,622</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNoteMember_zYAXkYSlLoUh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">20% OID Unsecured Convertible Notes Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,366,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,360,625</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--SeriesBPreferredConvertibleStockMember_zLW19Am3NGu7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Series B Preferred Convertible Stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">528,600</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--SeriesCWarrantsMember_zTtJOtgYusY8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Series C Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,181,419</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--SeriesEWarrantStockMember_zuYQ1gekERh4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Series E Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,347,476</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--NonConvertibleNotesMember_zCSNIBm45pna" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Non-Convertible Notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">850,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--OtherWarrantsMember_zMtHbKfjpqb2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,060,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">850,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--ConvertibleNotesPayableGross_iI_zpfwMDpe4CHb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,955,770</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,786,972</td><td style="text-align: left"> </td></tr> </table> Transactions involving stock warrants issued are summarized as follows: SCHEDULE OF STOCK WARRANT ISSUED <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%">Outstanding at December 31, 2025:</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zVUjcdbescwe" style="width: 14%; text-align: right" title="Outstanding, number of shares, beginning">15,786,972</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zLtk1GUxWSh7" style="text-align: right" title="Outstanding, number of shares, issued">6,168,798</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_ze1qwT0Rykri" style="text-align: right" title="Outstanding, number of shares, exercised">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zErztVr0P7Bi" style="border-bottom: Black 1pt solid; text-align: right" title="Outstanding, number of shares, expired">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30, 2026:</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zVlCrGasWg03" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, number of shares, ending balance">21,955,770</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0.9375

0.50

P5Y

0.9375

0.50

P5Y

0.85 1.50

P5Y

0.9375

0.50

P5Y

0.05

P5Y

850000

200000

P5Y

0.05

350000

P5Y

0.25

300000

150000

P5Y

0.9375

1210000

In connection with the issuance of the Series C Preferred Stock the Company issued warrants. 1,518,675 warrants from the 10% OID Senior Secured Convertible Promissory Note with Warrant, 2,692,423 warrants from the 35% OID Super Priority Convertible Promissory Note with Warrant, 528,000 from the Series B Preferred Convertible, 3,526,875 warrants from the 20% OID Unsecured Convertible Note Payable and 850,000 warrants from Other Non-Convertible Notes were exchanged for a total of 11,181,419 warrants.

1455450

2531199

466875

7347476

Warrants outstanding as of June 30, 2026, and December 31, 2025. SCHEDULE OF WARRANTS OUTSTANDING <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260630_zU1c0Ixm2Iv6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20251231_z7jnCQN3Syfd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--TenPercentOIDSeniorSecuredConvertibleNotesMember_zFtJoUQ6drX6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">10% OID Senior Secured Convertible Notes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">2,974,125</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--ThirtyFivePercentOIDSeniorSecuredConvertibleNotesMember_z1XCOx10umc5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">35% OID Super Priority Senior Secured Convertible Notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,223,622</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--TwentyPercentOIDSeniorSecuredConvertibleNoteMember_zYAXkYSlLoUh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">20% OID Unsecured Convertible Notes Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,366,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,360,625</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--SeriesBPreferredConvertibleStockMember_zLW19Am3NGu7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Series B Preferred Convertible Stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">528,600</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--SeriesCWarrantsMember_zTtJOtgYusY8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Series C Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,181,419</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--SeriesEWarrantStockMember_zuYQ1gekERh4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Series E Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,347,476</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--NonConvertibleNotesMember_zCSNIBm45pna" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Non-Convertible Notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">850,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ConvertibleNotesPayableGross_iI_hus-gaap--DebtInstrumentAxis__custom--OtherWarrantsMember_zMtHbKfjpqb2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,060,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">850,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--ConvertibleNotesPayableGross_iI_zpfwMDpe4CHb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,955,770</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,786,972</td><td style="text-align: left"> </td></tr> </table> 2974125 5223622 1366875 5360625 528600 11181419 7347476 850000 2060000 850000 21955770 15786972 Transactions involving stock warrants issued are summarized as follows: SCHEDULE OF STOCK WARRANT ISSUED <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%">Outstanding at December 31, 2025:</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zVUjcdbescwe" style="width: 14%; text-align: right" title="Outstanding, number of shares, beginning">15,786,972</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zLtk1GUxWSh7" style="text-align: right" title="Outstanding, number of shares, issued">6,168,798</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_ze1qwT0Rykri" style="text-align: right" title="Outstanding, number of shares, exercised">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zErztVr0P7Bi" style="border-bottom: Black 1pt solid; text-align: right" title="Outstanding, number of shares, expired">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30, 2026:</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zVlCrGasWg03" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, number of shares, ending balance">21,955,770</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

15786972

6168798

21955770

NOTE 7 – GOING CONCERN The accompanying consolidated financial statements have been prepared on a going concern basis of accounting which contemplates continuity of operations, realization of assets, liabilities, and commitments in the normal course of business. The accompanying consolidated financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company has a working capital deficit as of June 30, 2026, and has generated recurring net losses since its emergence from bankruptcy in April 2022. During the six months ending June, 2026, the Company experienced operating losses of approximately $1.267 million and corresponding cash inflows from operations of approximately $184,054. This performance reflected challenges in operating and restructuring the Company because of the previous issues that confronted the Company in the healthcare market, such as growing referral bases and negotiating favorable contract rates with third party payors for services rendered, as well as the negative impact of the CEO indictment in November 2018 and the bankruptcy from June 2020. As a result of the former CEO’s actions the Company has been subject to litigation as well as incurring damage to its relationships with its employees and referral sources. The Company’s ability to continue as a going concern is dependent upon the success of its continuing efforts to acquire profitable companies, grow its revenue base, reduce operating costs, especially as related to provider services, and access additional sources of capital, and/or sell assets. The Company believes that it will be successful in repairing its relationships with employees and referral sources, generating growth and improved profitability resulting in improved cash flow from operations. Additionally, headcount was reduced in October 2021 and again in January 2023 to generate reductions in operating costs while the Company focused on developing and executing its future business strategy. However, in order to execute the Company’s business development plan, which there can be no assurance we will achieve, the Company may need to raise additional funds through public or private equity offerings, debt financing, corporate collaborations or other means and potentially reduce operating expenditures. If the Company is unable to secure additional capital, it may have to curtail its business development initiatives and take additional measures to reduce costs in order to conserve its cash, thus raising substantial doubt about its ability to continue as a going concern more than one year from the date of issuance of the 2025 financial statements included in this filing.

-1267000

-184054

NOTE 8 – SUBSEQUENT EVENTS The Company evaluated its June 30, 2026, financial statements for subsequent events and transactions through August 7, 2026, the date the financial statements were available to be issued for possible disclosure and recognition in the financial statements. On July 22, 2026, the Company entered into a Business Combination Agreement with Westin Acquisition Corp. Concurrently with the execution of the Business Combination Agreement, the Company entered into binding agreements to acquire all of the outstanding equity interests of Pointe Medical Services, LLC, Point Medical Pharmacy, Inc., Live Well Drugstore, LLC and Live Well Drugstore, Inc. (collectively, the “Pointe Med Entities”), and the acquisitions of the Pointe Med Entities are expected to be consummated substantially concurrently with the Closing of the Business Combination.